Next-Generation Sequencing Panels Cost-Effective for Diagnosis of Hereditary Colorectal Cancer
A decision model finds that the higher cost of new sequencing methods is justified by their clinical benefits.
A decision model finds that the higher cost of new sequencing methods is justified by their clinical benefits.
FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.
Study of prostate cancer patients finds that treatment with GnRH agonists, but not antiandrogens, increases risk of cardiovascular events and mortality.
The t(11;14) translocation was associated with poorer response rates and shorter overall survival in patients treated with bortezomib-based regimens.
A retrospective analysis of crizotinib data demonstrates control in advanced, metastatic disease, although brain metastases continued to progress.
A large, retrospective cohort study found no evidence that metformin prevents lung cancer, although nonsmokers may find some benefit.
The transformation of the treatment of chronic lymphocytic leukemia wins the Society’s accolade.
Recent studies reveal the mechanisms underlying renal cell carcinoma (RCC) and suggest new therapeutic targets.
By analyzing data from international databases, researchers develop an alternative to the Child-Pugh system.
A new DNA vaccine caused mild side effects and a robust immune response to a breast cancer cell antigen.